Market Samachar
Home  ›  INDIAN
Language Englishతెలుగుहिन्दीதமிழ்मराठीবাংলাಕನ್ನಡ
SHARE MARKET TODAY · INDIAN ·

Cipla and SBP Group sign exclusive license agreement for Rolditamig Deuderuxtecan

As reported by Share Market Today
Used in treatment of HER2-low advanced breast cancer
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on Share Market Today ↗

Market Samachar is a news aggregator. This article was originally published by Share Market Today. Tap the button above to read the full story on their site.

🔥 Hot Now
Top stories across markets in the last hour

More from Market Samachar